Symptoms, Phenotypes, and Warning Signs
At a Glance
Symptoms of GLRX5-related disease vary: some people have small, pale red blood cells, fatigue, and early iron buildup, while others develop neurological or metabolic problems. Loss of skills, swallowing trouble, breathing difficulty, seizures, or blue skin require prompt medical attention.
Understanding the symptoms of GLRX5-related conditions requires looking at an incompletely understood spectrum of “presentations” or phenotypes (the way a genetic trait shows up in a person). Because this gene is involved in how every cell processes iron and energy, a mutation can affect the blood, the brain, or both [1][2].
The Isolated Anemia Phenotype
In some children and adults, the GLRX5 mutation primarily affects the production of red blood cells. This is known as isolated congenital sideroblastic anemia.
- Microcytic Anemia: The body produces red blood cells that are unusually small (microcytic) and pale [3]. Because these cells cannot carry oxygen efficiently, you may notice persistent pallor (paleness) and tiring easily during normal play or daily tasks.
- Early Iron Overload: Even before a person receives their first blood transfusion, systemic iron can begin to build up in the body. This happens because the body senses it doesn’t have enough red blood cells and tries to absorb more iron to compensate, but the GLRX5 mutation prevents that iron from being used correctly [4][5].
- Symptom Silence: Tissue iron overload is often completely “silent” or asymptomatic in its early stages. While symptoms like joint pain or extreme fatigue can occur, they are nonspecific and do not reliably indicate organ iron levels [6]. Regular monitoring of ferritin (a protein that stores iron), transferrin saturation trends, and clinical context is essential.
The Neurological and Metabolic Phenotype
In other reported cases, the mutation affects the nervous system more severely. This is sometimes called a “syndromic” form, and it can occur even if the child does not have anemia [7]. It is important to remember these are possible reported features, not inevitable symptoms for everyone with GLRX5:
- Metabolic Changes: This can include elevated glycine (an amino acid). This requires careful metabolic evaluation (such as screening for variant non-ketotic hyperglycinemia), which may cause “brain fog,” intellectual disability, or psychiatric changes [2][8].
- Motor Regression: One concerning sign is a loss of previously acquired motor skills (regression), such as the ability to crawl, sit, or walk [7][9].
- Spasticity: This refers to muscle stiffness or “tightness,” particularly in the legs (spastic paraparesis), which can make movement difficult or painful [2].
- Axonal Neuropathy: This is damage to the long fibers (axons) of the nerves, which can cause weakness, numbness, or “pins and needles” sensations in the hands and feet [8].
- Leukoencephalopathy: On an MRI, doctors may see changes in the “white matter” of the brain, which acts as the brain’s wiring system [2][7].
Symptom Triage: When to Seek Urgent Care
For individuals with the neurological or syndromic features of GLRX5, certain symptoms require prompt medical attention. If your team has provided an individualized emergency or sick-day plan, follow it carefully.
Seek Emergency Services (Call your local emergency number, e.g., 911) If:
- Active Airway Obstruction: If there is active choking, turning blue or grey (cyanosis), or severe respiratory distress, seek immediate emergency care. Aspiration (inhaling food/liquid) is a reported risk in severe syndromic GLRX5 cases and can lead to serious aspiration pneumonia [10][11].
- Severe Respiratory Distress: Watch for rapid breathing, “tugging” at the neck or ribs when breathing, or severely labored breathing [12][11].
- Acute Cardiac Issues: While very rare, severe mitochondrial abnormalities can lead to cardiac complications [10]. Seek emergency help for sudden fainting, severe swelling, or sudden cyanosis [13][14].
- Altered Consciousness: Sudden lethargy, unresponsiveness, or seizures.
Call Your Specialist for Prompt Clinical Assessment If:
- Feeding Difficulty: Recurrent coughing with meals or a “wet,” gurgly sound in the voice or breath indicates a need for a prompt feeding/swallow evaluation [15].
- Sudden Weakness: You notice a new or rapid loss of a physical skill, like being unable to hold the head up or a sudden change in walking [9].
- Persistent Vomiting: Frequent vomiting in children with mitochondrial disorders can lead to dangerous metabolic imbalances; this may require evaluation or IV fluids [16].
Monitoring these signs closely allows for earlier intervention, which is critical in managing such a complex condition.
Common questions in this guide
What symptoms can GLRX5-related sideroblastic anemia cause?
Can GLRX5-related disease cause neurological problems without anemia?
How is iron overload monitored in GLRX5-related disease?
Should glycine or other metabolic tests be checked in GLRX5-related disease?
Which GLRX5 symptoms require emergency care?
When should I call a specialist about feeding or movement changes?
Get notified when new evidence is published on anemia, sideroblastic, 5.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (16)
- 1
Functional Analysis of GLRX5 Mutants Reveals Distinct Functionalities of GLRX5 Protein.
Liu G, Wang Y, Anderson GJ, et al.
Journal of cellular biochemistry 2016; (117(1)):207-17 doi:10.1002/jcb.25267.
PMID: 26100117 - 2
GLRX5-associated [Fe-S] cluster biogenesis disorder: further characterisation of the neurological phenotype and long-term outcome.
Sankaran BP, Gupta S, Tchan M, et al.
Orphanet journal of rare diseases 2021; (16(1)):465 doi:10.1186/s13023-021-02073-z.
PMID: 34732213 - 3
GLRX5 mutations impair heme biosynthetic enzymes ALA synthase 2 and ferrochelatase in Human congenital sideroblastic anemia.
Daher R, Mansouri A, Martelli A, et al.
Molecular genetics and metabolism 2019; (128(3)):342-351 doi:10.1016/j.ymgme.2018.12.012.
PMID: 30660387 - 4
Pathophysiology and classification of iron overload diseases; update 2018.
Brissot P, Troadec MB, Loréal O, Brissot E
Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine 2019; (26(1)):80-88 doi:10.1016/j.tracli.2018.08.006.
PMID: 30173950 - 5
Clinical characterization and hematopoietic stem cell transplant outcomes for congenital sideroblastic anemia caused by a novel pathogenic variant in SLC25A38.
Uminski K, Houston DS, Hartley JN, et al.
Pediatric blood & cancer 2020; (67(10)):e28623 doi:10.1002/pbc.28623.
PMID: 32790119 - 6
[Successful treatment of X-linked sideroblastic anemia with ALAS2 R452H mutation using vitamin B6].
Kawakami T, Nakazawa H, Kawakami F, et al.
[Rinsho ketsueki] The Japanese journal of clinical hematology 2018; (59(4)):401-406 doi:10.11406/rinketsu.59.401.
PMID: 29743399 - 7
Teaching NeuroImage: Glutaredoxin-5-Associated Variant Nonketotic Hyperglycinemia.
Roy Chowdhury S, Mittal R, Yadav R, Guglany V
Neurology 2024; (102(3)):e208105 doi:10.1212/WNL.0000000000208105.
PMID: 38175985 - 8
Case Report: A Variant Non-ketotic Hyperglycinemia With GLRX5 Mutations: Manifestation of Deficiency of Activities of the Respiratory Chain Enzymes.
Feng WX, Zhuo XW, Liu ZM, et al.
Frontiers in genetics 2021; (12()):605778 doi:10.3389/fgene.2021.605778.
PMID: 34054912 - 9
TTC19-related mitochondrial disease: A characteristic neuroimaging signature?
Bérat CM, Barcia G, Gaignard P, et al.
Molecular genetics and metabolism 2026; (149(1-2)):110220 doi:10.1016/j.ymgme.2026.110220.
PMID: 42480132 - 10
Infant With a Severe Form of GLRX5-Related Atypical Hyperglycinemia Exhibiting Novel Cardiac and Neurologic Disease Manifestations at Autopsy.
Ferreira EO, Del Bigio MR, Morin J, Frosk P
Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society 2025; (28(5)):390-394 doi:10.1177/10935266251335065.
PMID: 40415601 - 11
How to use the videofluoroscopy swallow study in paediatric practice.
Batchelor G, McNaughten B, Bourke T, et al.
Archives of disease in childhood. Education and practice edition 2019; (104(6)):313-320 doi:10.1136/archdischild-2017-313787.
PMID: 30322859 - 12
Leigh Syndrome due to MT-ATP6 Variants: A Case Presentation and the Review of the Literature.
Akar HT, Sayar E, Sarıtaş Nakip Ö, et al.
Molecular syndromology 2024; (15(4)):333-338 doi:10.1159/000536676.
PMID: 39119452 - 13
Mitochondrial Genome Variants as a Cause of Mitochondrial Cardiomyopathy.
Campbell T, Slone J, Huang T
Cells 2022; (11(18)) doi:10.3390/cells11182835.
PMID: 36139411 - 14
Cardiac transplant outcomes in a pediatric patient with novel homozygous variants in TOP3Α causing mitochondrial dysfunction.
Ganesh J, Donnelly C, Ligezka A, et al.
Molecular genetics and metabolism 2025; (146(3)):109236 doi:10.1016/j.ymgme.2025.109236.
PMID: 41075683 - 15
Primary mitochondrial myopathies in childhood.
Olimpio C, Tiet MY, Horvath R
Neuromuscular disorders : NMD 2021; (31(10)):978-987 doi:10.1016/j.nmd.2021.08.005.
PMID: 34736635 - 16
De Novo DNM1L Mutation in a Patient with Encephalopathy, Cardiomyopathy and Fatal Non-Epileptic Paroxysmal Refractory Vomiting.
Berti B, Verrigni D, Nasca A, et al.
International journal of molecular sciences 2024; (25(14)) doi:10.3390/ijms25147782.
PMID: 39063023
This page is for informational purposes only and does not constitute medical advice. A hematology, neurology, or metabolic specialist should interpret symptoms and guide urgent evaluation for your specific situation.